Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

TDR Insider

Some Labs Report Faster Pay For Molecular, Genetic Tests via New CPT Code Reimbursement Program

TDR Insider / By Mary Van Doren

DURING RECENT MONTHS, some labs are reporting improvement in how their claims for certain molecular and genetic tests are being reimbursed. This is progress from the financial crises experienced during 2013 for many labs performing molecular and genetic tests. Disruption in these payments was one of the clinical lab industry’s biggest stories during 2013. There …

Some Labs Report Faster Pay For Molecular, Genetic Tests via New CPT Code Reimbursement Program Read More »

To access this post, you must purchase The Dark Report.

New Laboratory Industry Trend: Labs Must Prepare for End of Fee-for-Service Model

TDR Insider / By Mary Van Doren

CEO SUMMARY: One stark difference between the presentations delivered at last year’s Executive War College and this year’s presentations in New Orleans last week was near-unanimous recognition that the era of fee-for-service payment is soon to end! Speaker after speaker urged the audience to accept this marketplace reality in laboratory industry trends. The common recommendation …

New Laboratory Industry Trend: Labs Must Prepare for End of Fee-for-Service Model Read More »

To access this post, you must purchase The Dark Report.

Theranos: Many Questions, but Very Few Answers

TDR Insider / By Mary Van Doren

CEO SUMMARY: Winston Churchill famously said that “Russia is a riddle wrapped in a mystery inside an enigma.” That description could apply to Theranos, the company that claims it is poised to disrupt the entire clinical laboratory testing industry. In Phoenix, where Theranos is ramping up its clinical lab marketing and operations, competing lab companies have it under the microscope. Some say not all may be going to plan and Theranos has been asked to comment on several issues.

To access this post, you must purchase The Dark Report.

Top laboratory management requires top business skills

TDR Insider / By Mary Van Doren

Every lab organization should aspire to achieve the attributes of Level Four: Use Benchmarks to Achieve Best-in-Class because this is the level of performance where the lab is delivering optimal clinical value at highest quality and lowest cost. This is an effort in which the business skills of laboratory management come to the fore. It …

Top laboratory management requires top business skills Read More »

To access this post, you must purchase The Dark Report.

Early Experience with Accountable Care Organization Has Lessons for Pathologists

TDR Insider / By Mary Van Doren

CEO SUMMARY: To date, many of the nation’s 500 accountable care organizations have launched with little involvement by independent pathology groups and clinical laboratories. That was not the case with an ACO in Alabama, however. From its inception in 2012, the ACO has contracted with CytoPath, P.C., a five-pathologist group in Alabaster, Alabama. CytoPath’s pathologists are currently paid on a fee-for-service basis and must provide detailed and timely data to the ACO.

To access this post, you must purchase The Dark Report.

Protecting Access to Medicare Act of 2014 Could Harm Independent Community Labs

TDR Insider / By Mary Van Doren

In the Protecting Access to Medicare Act of 2014 (PAMA), the Center for Medicare and Medicaid Services (CMA) is directed to collect market price data and use the data to establish prices for the Part B Clinical Laboratory Fee Schedule, starting on January 1, 2017.

To access this post, you must purchase The Dark Report.

UCLA Pathologists, Radiologists Produce Integrated Diagnostic Lab Reports

TDR Insider / By Mary Van Doren

CEO SUMMARY: To simplify diagnostic reporting, the pathology and radiology departments at the David Geffen School of Medicine/UCLA Medical Center are working together to deliver integrated diagnostic information to treating oncologists. This innovative strategy is designed to improve patient care and quality while saving time and cutting costs. For five months, diagnosticians have worked together on more than 50 lung cancer cases while gathering the evidence to show this interdisciplinary approach can improve decision-making and reduce downstream treatment costs.

To access this post, you must purchase The Dark Report.

Healthcare Cost Solutions Will Continue to Pinch Lab Industry Revenues in 2015

TDR Insider / By Mary Van Doren

CEO SUMMARY: Will 2015 turn out to be a watershed year for the clinical laboratory industry? With healthcare cost solutions continuing to squeeze laboratory profits, two federal agencies are pushing forward with initiatives that will touch nearly every medical lab in the United States in the next 12 months. Other equally powerful trends continue to negatively influence the prices labs are paid for their testing services. All these factors make it essential for lab administrators and pathologist business leaders to work proactively to maintain their lab’s financial stability.

To access this post, you must purchase The Dark Report.

;